+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
MALE
ID07168616

Evaluating Istanbul PSMA PETCT Criteria to Guide Active Surveillance in Men with Low-Risk Prostate Cancer

Led by Istanbul University - Cerrahpasa · Updated on 2025-09-15

201

Participants Needed

10

Research Sites

89 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the Istanbul PSMA PETCT Criteria IPPC to improve the selection of men with biopsy-confirmed low-risk prostate cancer ISUP Grade 1 for active surveillance. This multicenter, prospective diagnostic accuracy study aims to refine patient classification by integrating delayed Ga-68 PSMA PETCT imaging, potentially reducing unnecessary biopsies and MRI scans while avoiding under-treatment of higher-risk patients. The study compares IPPC with standard mpMRI and biopsy results, using radical prostatectomy pathology or long-term clinical follow-up as benchmarks. Participants undergo delayed 120-minute Ga-68 PSMA PETCT scans assessed by the IPPC, which categorizes prostate lesions into three risk levels low uptake safe for monitoring, indeterminate uptake active surveillance with close follow-up, and high uptake recommendation for treatment. This procedure is added to the existing diagnostic pathway involving mpMRI and prostate biopsy performed within three months before enrollment. During the study, participants diagnostic results will be monitored against clinical outcomes, including pathology from prostatectomy or follow-up over two years. Researchers will measure the diagnostic accuracy of IPPC for detecting clinically significant prostate cancer and assess its impact on reducing repeat biopsy rates. Participants must have no prior PSMA PET imaging and will be followed according to the studys schedule, with safety and effectiveness monitored through imaging and clinical data over the study period.

CONDITIONS

Brief Title

Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance

Research Team

L

Levent Kabasakal, Prof. MD

N

Nalan Alan, Prof. MD.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here